Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
11/21/2025 | CALL | $190.00 | 11,404 | +10,001 | +712.83% |
10/17/2025 | CALL | $185.00 | 3,219 | +492 | +18.04% |
09/12/2025 | CALL | $182.50 | 1,089 | +337 | +44.81% |
09/12/2025 | CALL | $180.00 | 1,881 | +227 | +13.72% |
10/17/2025 | PUT | $170.00 | 4,105 | +156 | +3.95% |
09/12/2025 | PUT | $175.00 | 2,323 | +139 | +6.36% |
11/21/2025 | CALL | $175.00 | 5,795 | -53 | -0.91% |
11/21/2025 | CALL | $185.00 | 3,375 | -58 | -1.69% |
09/19/2025 | CALL | $190.00 | 1,588 | -67 | -4.05% |
12/19/2025 | PUT | $160.00 | 552 | -76 | -12.10% |
06/18/2026 | CALL | $190.00 | 548 | -82 | -13.02% |
10/17/2025 | CALL | $175.00 | 14,446 | -861 | -5.62% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Vanguard Total Stock Market Index Fund | 2.55% | 79.47M | 12.56B |
Vanguard 500 Index Fund | 1.94% | 60.44M | 9.55B |
Fidelity 500 Index Fund | 0.92% | 28.66M | 4.53B |
SPDR S&P 500 ETF Trust | 0.91% | 28.31M | 4.47B |
iShares Core S&P 500 ETF | 0.75% | 23.33M | 3.69B |
Vanguard Index-Value Index Fund | 0.72% | 22.6M | 3.57B |
Select Sector SPDR Fund-Health Care | 0.68% | 21.24M | 3.36B |
Vanguard Institutional Index Fund-Institutional Index Fund | 0.59% | 18.32M | 2.9B |
Vanguard Specialized-Dividend Appreciation Index Fund | 0.53% | 16.62M | 2.63B |
Washington Mutual Investors Fund | 0.40% | 12.37M | 1.96B |
Numab Therapeutics Announces Leadership Transition and Appoints Angehrn Pavik as Chief Executive Officer
09/09 08:00 am
GlobeNewswire Inc.
Read moreData published in The New England Journal of Medicine demonstrate RYBREVANT®▼(amivantamab) plus LAZCLUZE®▼ (lazertinib) could re-set survival expectations in first-line EGFR-mutated advanced lung cancer
09/07 03:28 am
GlobeNewswire Inc.
Read moreRYBREVANT®▼ (amivantamab) plus LAZCLUZE®▼ (lazertinib) reduces acquired resistance versus osimertinib in first-line EGFR-mutated advanced non-small cell lung cancer
09/06 03:10 am
GlobeNewswire Inc.
Read moreGlobal Colorectal Surgical Devices Market to Advance at Moderate CAGR of ~8% by 2032 | DelveInsight
09/04 01:00 pm
GlobeNewswire Inc.
Read moreSoftware Automation in Research and Development (R&D) Clinical Trials Training Course | Harnessing Automation Technology to Deliver Faster, Cost-Effective Outcomes (Oct 1, 2025)
09/04 10:00 am
GlobeNewswire Inc.
Read moreCould These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?
09/04 04:09 am
The Motley Fool
Read moreMultiple Myeloma Market Size Projected USD 49.89 Billion by 2034
09/03 11:00 am
GlobeNewswire Inc.
Read moreHealthcare Valuations Near Multi-Year Lows Suggest Risk–Reward Asymmetry
09/02 09:37 am
Investing.com
Read moreGrand River Aseptic Manufacturing (GRAM) Appoints Denis Johnson as Chief Executive Officer
09/02 09:00 am
GlobeNewswire Inc.
Read moreAcne Medicine Market Size Projected to Reach USD 23.33 Billion by 2034
09/01 10:00 am
GlobeNewswire Inc.
Read moreThese 4 Dividend Stocks Are Money-Printing Machines
08/31 02:10 pm
The Motley Fool
Read moreDermatology Market to Worth USD 2.75 Billion Size by 2034
08/29 11:00 am
GlobeNewswire Inc.
Read moreSGLT2 Inhibitors Market to Hit USD 29.73 Billion by 2032, Driven by Expanding Diabetes Management and Cardiovascular Benefits – SNS Insider
08/29 09:00 am
GlobeNewswire Inc.
Read moreGlobal Pharmaceuticals Market to Register Immense Growth at a CAGR of ~7% by 2032 | DelveInsight
08/27 01:00 pm
GlobeNewswire Inc.
Read moreMaxion Therapeutics Strengthens Board with Appointment of Dr. Santiago Arroyo as a Non-Executive Director
08/27 08:00 am
GlobeNewswire Inc.
Read moreChronic Inducible Urticaria (CIndU) Market Research Report 2025-2035 | Competitive Analysis of AstraZeneca, Celldex Therapeutics, J&J, Merck, Novartis, Pfizer, Regeneron Pharma, Sanofi, Sun Pharma
08/27 04:50 am
GlobeNewswire Inc.
Read moreAs the Market Rotates, This Healthcare ETF Is Leading the Way
08/26 10:07 am
Investing.com
Read moreShould You Buy Intuitive Surgical Stock Today, or Wait for a Better Price?
08/25 05:11 am
The Motley Fool
Read moreGot $500? 3 Dividend Stocks to Buy and Hold Forever
08/25 04:04 am
The Motley Fool
Read moreGlobal Surgical Sutures Market Poised to Reach USD 6.65 Billion by 2030 | MarketsandMarkets™
08/22 08:00 am
GlobeNewswire Inc.
Read moreUnderstanding the Nanomedicine Landscape: Key Players and Emerging Trends
08/21 04:38 am
GlobeNewswire Inc.
Read moreGlobal Tissue Engineering and Regeneration Market Set to Surge at 12.8% CAGR Through 2030
08/19 01:54 pm
GlobeNewswire Inc.
Read moreMassive Headwinds Are on the Horizon for Pharmaceutical Stocks, but Here Are 2 That Could Weather the Storm
08/17 07:23 pm
The Motley Fool
Read moreThese Are the 3 Smartest Dividend Stocks Today
08/16 10:30 am
The Motley Fool
Read more3 Mega-Caps That Outperformed Expectations This Earnings Season
08/14 11:03 am
Investing.com
Read moreMeiraGTx Sales Jump 1,133 Percent
08/14 08:31 am
The Motley Fool
Read moreIf You're In Your 20's, Consider Buying These 3 Healthcare Stocks
08/13 06:05 am
The Motley Fool
Read moreVicarious Surgical Narrows Loss in Q2
08/12 10:29 pm
The Motley Fool
Read more3 Big Dividend Plays With Strong Earnings to Back Them
08/11 12:21 pm
Investing.com
Read moreNovartis' Investigational Drug Aces Two Pivotal Trials For Chronic Disease Impacting Tears, Saliva
08/11 09:53 am
Benzinga
Read more5 Dividend Stocks to Hold for the Next 5 Years
08/09 06:14 pm
The Motley Fool
Read moreOncolytics Biotech® Reports Second Quarter Financial Results and Details Clinical Program Plans for Pelareorep
08/08 09:05 am
Benzinga
Read moreSpinal Fusion Devices Market Outlook Report 2025-2029: Revenues to Grow by $2.9 Billion Driven by Rising Spinal Disorders, Technological Advances, and Increasing Device Launches
08/08 04:49 am
GlobeNewswire Inc.
Read moreRxSight (RXST) Q2 Loss Beats Estimates
08/07 06:23 pm
The Motley Fool
Read moreProtagonist (PTGX) Q2 Revenue Falls 26%
08/07 12:34 am
The Motley Fool
Read moreContineum (CTNM) Q2 R&D Jumps 78%
08/05 11:34 pm
The Motley Fool
Read moreAAV for the Hereditary Retinal Diseases Clinical Trial Pipeline Analysis Demonstrates 70+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight
08/05 01:00 pm
GlobeNewswire Inc.
Read moreHematologist Dissatisfaction with Current Warm Autoimmune Hemolytic Anemia (w-AIHA) Treatment Spurs Interest in Late-Stage Pipeline, According to Spherix Global Insights
07/29 01:51 pm
GlobeNewswire Inc.
Read more2 Unstoppable Dow Dividend Stocks to Buy and Hold Forever
07/28 08:29 pm
The Motley Fool
Read moreThese 3 Dow Stocks Are Set to Soar in 2025 and Beyond
07/27 03:15 am
The Motley Fool
Read moreOncology Drugs Market Insights, Competitive Landscape, and Forecast Report 2025-2032 | Immunotherapy Leads Growth in Oncology Market Due to Better Precision and Fewer Side Effects
07/25 10:50 am
GlobeNewswire Inc.
Read moreAstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate
07/24 01:08 pm
Benzinga
Read moreGlobal Dysmenorrhea Treatment Market to Cross ~USD 8 Billion by 2032 | DelveInsight
07/23 01:00 pm
GlobeNewswire Inc.
Read more4 Major Stocks Raise 2025 Guidance, Analyst Targets Rise
07/23 08:37 am
Investing.com
Read moreIpsen announces changes to its Executive Committee
07/23 01:30 am
GlobeNewswire Inc.
Read moreIpsen annonce des changements au sein de son Comité Exécutif
07/23 01:30 am
GlobeNewswire Inc.
Read moreBispecific Antibodies Market Set to Surge to $163.15 Billion by 2032, Driven by a Robust 40.1% CAGR | Roche, Amgen, and Johnson & Johnson at the Forefront: AnalystView Market Insights
07/22 03:20 am
GlobeNewswire Inc.
Read more10 Magnificent S&P 500 Dividend Stocks Down Over 10% to Buy and Hold Forever
07/20 05:01 am
The Motley Fool
Read more